@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP707849.RA7FmQDmcjk9ge5XoHT8hMqCLsMx23PfXD0WT88aYqyjQ130_head { this: np:hasAssertion dgn-np:NP707849.RA7FmQDmcjk9ge5XoHT8hMqCLsMx23PfXD0WT88aYqyjQ130_assertion; np:hasProvenance dgn-np:NP707849.RA7FmQDmcjk9ge5XoHT8hMqCLsMx23PfXD0WT88aYqyjQ130_provenance; np:hasPublicationInfo dgn-np:NP707849.RA7FmQDmcjk9ge5XoHT8hMqCLsMx23PfXD0WT88aYqyjQ130_publicationInfo; a np:Nanopublication . dgn-np:NP707849.RA7FmQDmcjk9ge5XoHT8hMqCLsMx23PfXD0WT88aYqyjQ130_assertion a np:Assertion . dgn-np:NP707849.RA7FmQDmcjk9ge5XoHT8hMqCLsMx23PfXD0WT88aYqyjQ130_provenance a np:Provenance . dgn-np:NP707849.RA7FmQDmcjk9ge5XoHT8hMqCLsMx23PfXD0WT88aYqyjQ130_publicationInfo a np:PublicationInfo . } dgn-np:NP707849.RA7FmQDmcjk9ge5XoHT8hMqCLsMx23PfXD0WT88aYqyjQ130_assertion { miriam-gene:9768 a ncit:C16612 . lld:C0035372 a ncit:C7057 . dgn-gda:DGN3e374d1c20d44a83f0cdf4ed1ddffb21 sio:SIO_000628 miriam-gene:9768, lld:C0035372; a sio:SIO_001121 . } dgn-np:NP707849.RA7FmQDmcjk9ge5XoHT8hMqCLsMx23PfXD0WT88aYqyjQ130_provenance { dgn-np:NP707849.RA7FmQDmcjk9ge5XoHT8hMqCLsMx23PfXD0WT88aYqyjQ130_assertion dcterms:description "[This approach provided a `metabolic window` to brain characteristics in Mecp2-null mice (n = 4), revealing (i) the first metabolic evidence of astrocyte involvement in RS (decreased levels of the astrocyte marker, myo-inositol, vs. wild-type mice; p = 0.034); (ii) reduced choline phospholipid turnover in Mecp2-null vs. wild-type mice, implying a diminished potential of cells to grow, paralleled by globally reduced brain size and perturbed osmoregulation; (iii) alterations of the platelet activating factor (PAF) cycle in Mecp2-null mouse brains, where PAF is a bioactive lipid acting on neuronal growth, glutamate exocytosis and other processes; and (iv) changes in glutamine/glutamate ratios (p = 0.034) in Mecp2-null mouse brains potentially indicating altered neurotransmitter recycling.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:17237885; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP707849.RA7FmQDmcjk9ge5XoHT8hMqCLsMx23PfXD0WT88aYqyjQ130_publicationInfo { this: dcterms:created "2014-10-02T12:39:10+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }